Sanofi announces insulin price cap after actions by Ely Lilly and Novo Nordisk

Sanofi Follows Lilly, Novo Nordisk in Cutting Insulin Prices

FRIDAY, March 17, 2023 (HealthDay News) -- On Thursday, Sanofi became the third company to announce it will slash prices on its insulin products.

Sanofi becomes latest drugmaker to announce insulin price cuts

Another drug maker is cutting the price of insulin.Thursday, Sanofi announced it is dropping the price of 'Lantus' by 78%Lantus is the company's most widely pre

Sanofi to cut U.S. insulin prices by up to 78%, capping cost at $35

Sanofi is cutting the list price of its insulin in the U.S. by 78%, establishing a $35 monthly cap for the privately insured.

Sanofi to cut U.S. insulin prices by up to 78%, capping cost at $35

Sanofi is cutting the list price of its insulin in the U.S. by 78%, establishing a $35 monthly cap for the privately insured.

Sanofi to cut U.S. insulin prices by up to 78%, capping cost at $35

Sanofi is cutting the list price of its insulin in the U.S. by 78%, establishing a $35 monthly cap for the privately insured.

Sanofi to cut U.S. insulin prices by up to 78%, capping cost at $35

Sanofi is cutting the list price of its insulin in the U.S. by 78%, establishing a $35 monthly cap for the privately insured.